,
6 min read
Software as a Medical Device does not move in linear release cycles. It evolves. Algorithms are refined, cybersecurity patches are deployed, user interfaces are optimized, and integrations expand. For manufacturers, this dynamic reality shifts the regulatory question from “How do we get approval?” to “How do we sustain compliance as the product changes?”
This is where SaMD lifecycle management becomes strategically decisive. Unlike hardware-based devices, SaMD exists in a continuous state of improvement. Each update whether minor or material must be evaluated through the lens of risk, clinical performance, and global regulatory obligations.
Lifecycle management, therefore, is not just an engineering discipline. It is a regulatory governance system that determines how organizations interpret SaMD regulation, document changes, and justify decisions across markets.
From Approval to Continuous Oversight: The Lifecycle Mindset
Historically, regulatory success was defined by premarket authorization. Today, SaMD compliance is increasingly judged by how effectively manufacturers manage updates after launch. Regulators expect evidence that change is controlled, traceable, and justified.
The International Medical Device Regulators Forum (IMDRF) has long framed this through a total product lifecycle approach. The foundational work on IMDRF software as a medical device emphasizes that software risk does not end at market entry; it must be managed throughout development, deployment, and post-market monitoring.
This lifecycle framing has influenced SaMD regulations globally from FDA expectations around change control and predetermined change management for AI/ML systems to EU MDR requirements for technical documentation updates and post-market surveillance.
The shift is clear: regulators are less concerned with static documentation and more concerned with governance systems that can handle evolution responsibly.
Manufacturing Software Updates: When Does a Change Become Regulatory?
Not every software update triggers regulatory notification, but every update requires disciplined evaluation. The core question is not whether something changed but whether the change affects:
- Intended use or labelling
- Risk profile
- Clinical performance
- Cybersecurity posture
- Interoperability or data inputs
A mature SaMD lifecycle management framework categorizes updates into corrective, adaptive, or enhancement-driven changes, then maps each category to predefined regulatory decision pathways.
For example, in the United States, FDA’s evolving digital health oversight particularly for AI-enabled products demonstrates that predictable change control mechanisms are preferred over ad hoc justification. The FDA’s SaMD resource page provides insight into how the agency frames lifecycle-based oversight reinforcing how regulations for SaMD are increasingly structured around controlled iteration rather than static approval.
Change Management as a Regulatory Control System
Effective change management is not about documenting what happened it is about defining what must happen before change is approved.
A strong framework typically includes:
- Structured impact assessment against risk management files
- Evaluation of whether verification or validation scope must expand
- Documentation of rationale for regulatory notification (or non-notification)
- Cross-functional approval before release
This is where governance discipline matters. If change decisions rely solely on engineering judgment without regulatory alignment, inconsistencies emerge across versions and markets. Over time, that erodes defensibility under audit.
The most resilient systems treat change assessment as a repeatable, auditable process one that aligns product velocity with SaMD compliance obligations across jurisdictions.
Version Control: Beyond Source Code Management
Version control is often misunderstood as a purely technical discipline. In regulated SaMD environments, it is a traceability discipline.
Regulators expect clear lineage between:
- Software versions
- Risk control implementations
- Validation evidence
- Released configurations in the field
This becomes particularly critical when investigating complaints, field safety corrective actions, or cybersecurity vulnerabilities. Without version-level traceability, organizations struggle to demonstrate containment and root cause analysis.
The IMDRF’s lifecycle documents emphasize documentation consistency and traceability as foundational to IMDRF SaMD governance. Version control, therefore, is not merely operational hygiene it is a compliance safeguard embedded within broader SaMD regulation frameworks.
AI, Adaptive Algorithms, and Regulatory Decision-Making
AI-enabled SaMD has accelerated the complexity of lifecycle oversight. Traditional validation assumed relatively stable codebases. AI systems, however, may shift behaviour as models are retrained or exposed to new data distributions.
This reality has driven regulators to formalize lifecycle-oriented oversight models. In the EU context, the intersection of MDR obligations and the EU AI Act is reshaping expectations around transparency, monitoring, and change governance. The official legal framework for the AI Act, available through EUR-Lex , signals that adaptive AI systems will be assessed not just for initial performance but for sustained control mechanisms.
For manufacturers, this reinforces a critical principle, i.e., regulatory decisions must be built into update design. Whether through predetermined change protocols, predefined retraining boundaries, or real-time performance monitoring, adaptive systems require proactive governance not reactive justification.
Global Consistency in Lifecycle Decisions
A software update that is considered minor in one jurisdiction may be treated differently in another. This is where SaMD global regulatory strategy becomes essential.
Global manufacturers must harmonize lifecycle decisions across:
- FDA expectations for change notifications
- EU MDR technical documentation updates
- Country-specific post-market reporting obligations
A fragmented approach where each region evaluates changes independently creates inconsistency and increases regulatory risk. A unified decision framework, applied globally but interpreted locally, preserves coherence across markets.
This alignment is especially important as SaMD regulations continue to evolve in response to cybersecurity risks, AI governance, and real-world performance monitoring.
Lifecycle Governance as Competitive Maturity
The most advanced SaMD organizations do not treat lifecycle management as an operational burden. They treat it as a system that enables sustainable innovation.
Strong governance systems demonstrate:
- Clear thresholds for significant vs. non-significant change
- Integrated risk and validation review for each release
- Transparent documentation linking versions to evidence
- Post-market monitoring that informs future updates
When these elements are embedded into operating culture, lifecycle management becomes predictable and defensible two qualities regulators increasingly value more than static documentation completeness.
In practice, teams that approach lifecycle oversight as a structured governance discipline rather than a reactive compliance exercise tend to align more effectively with the expectations outlined in Comprehensive Guide to Software as a Medical Device (SaMD) Compliance & Global Registration and operational frameworks reflected in Software as a Medical Device (SaMD) Regulatory Compliance.
Contact Freyr Solutions to discuss your SaMD Regulatory strategy and discover how Freyr can streamline your global registrations.
Closing Perspective
SaMD does not end at launch. It matures, adapts, and improves. The question regulators now ask is not whether software can innovate but whether manufacturers can control that innovation responsibly.
Effective SaMD lifecycle management integrates engineering rigor, regulatory foresight, and global alignment. It ensures that updates are not just deployed but justified, documented, and defensible under evolving regulations for SaMD.
In a regulatory environment shaped by adaptive oversight, AI governance, and expanding post-market expectations, lifecycle discipline is no longer optional. It is the foundation of durable SaMD compliance and sustainable global growth.
